Psychedelics Archives - Page 36 of 68

2 minute read

Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More

April 3, 5:12 PM

Colorado and Leiden-based biotech company Mydecine Innovations Group (OTC: MYCOF) has shared its financial results and business highlights for the period ended December 31, 2022. In ciphers:

MYCOF

3 minute read

The Happy Chef Celebrates 10-Year Anniversary Of Cannabis Cookbook Ft. B-Real, Expands Collection And Ventures Into Psychedelics

By Javier Hasse

April 3, 4:37 PM

Dee Russell, better known as Edible Dee - The Happy Chef, is celebrating the 10-year anniversary of her cannabis cookbook.

CURLF

1 minute read

MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update

By Lara Goldstein

April 3, 3:46 PM

Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and development activities for its proprietary transdermal microneedle patch to deliver MDMA toward IND-enabling studies, supported by an exclusive supply deal with PharmaAla Biotech Holdings Inc.

PHRRF

3 minute read

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry

By Javier Hasse

April 3, 2:05 PM

The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.

BWVI

2 minute read

Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill

By Lara Goldstein

April 3, 1:44 PM

The natural psychedelics company responsible for creating the first standardized ayahuasca capsule, Filament Health Corp.

FLHLF

2 minute read

Psychedelics For Major Depressive Disorder And Anxiety Disorders: Data Suggests Cybin’s Deuterated Analogs Could Work

By Javier Hasse

April 3, 9:49 AM

Cybin Inc (NYSE: CYBN) recently provided updates on its innovative treatments for Major Depressive Disorder (MDD) and Anxiety Disorders during its Investor Day.

CYBN